$BFYW
Better For You Wellness, Inc. Stock $bfyw

$bfyw Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000157587224001005 Filed on September 16, 2024

Income Statement

Concept	2024 Q2	2023 Q2
Revenue	$5.690K	$1.850K
YoY Change	207.57%	-85.87%
Cost Of Revenue	$5.319K	$930.00
YoY Change	471.94%	-90.94%
Gross Profit	$370.00	$920.00
YoY Change	-59.78%	-67.38%
Gross Profit Margin	6.5%	49.73%
Selling, General & Admin	$225.4K	$705.0K
YoY Change	-68.03%	-6.87%
% of Gross Profit	60922.7%	76631.52%
Research & Development	$0.00	$0.00
YoY Change
% of Gross Profit	0.0%	0.0%
Depreciation & Amortization	$1.342K	$190.00
YoY Change	606.32%	0.0%
% of Gross Profit	362.7%	20.65%
Operating Expenses	$226.0K	$705.0K
YoY Change	-67.95%	-6.87%
Operating Profit	-$225.6K	-$704.1K
YoY Change	-67.96%	-6.64%
Interest Expense	-$43.54K	-$43.80K
YoY Change	-0.59%	20.43%
% of Operating Profit
Other Income/Expense, Net	-$43.54K	-$43.80K
YoY Change	-0.59%	5.71%
Pretax Income	-$269.1K	-$747.9K
YoY Change	-64.01%	-45.53%
Income Tax
% Of Pretax Income
Net Earnings	-$269.1K	-$747.9K
YoY Change	-64.01%	-45.53%
Net Earnings / Revenue	-4730.07%	-40426.49%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding		404.2M
Diluted Shares Outstanding	486.0M	404.1M

Balance Sheet

Concept	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.030K	$17.78K
YoY Change	-88.58%	558.52%
Cash & Equivalents	$2.026K	$17.78K
Short-Term Investments
Other Short-Term Assets	$17.38K	$10.93K
YoY Change	59.01%	-86.0%
Inventory	$54.99K	$420.00
Prepaid Expenses	$17.38K	$10.93K
Receivables	$8.565K	$2.010K
Other Receivables	$0.00	$19.86K
Total Short-Term Assets	$82.96K	$50.99K
YoY Change	62.69%	424.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.918K	$215.4K
YoY Change	-98.18%	35204.92%
Goodwill		$583.5K
YoY Change		-0.02%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$134.7K	$798.8K
YoY Change	-83.14%	130857.38%
TOTAL ASSETS
Total Short-Term Assets	$82.96K	$50.99K
Total Long-Term Assets	$134.7K	$798.8K
Total Assets	$217.6K	$849.8K
YoY Change	-74.39%	8118.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$923.7K	$564.8K
YoY Change	63.55%	249.02%
Accrued Expenses	$67.76K	$72.91K
YoY Change	-7.06%	349.51%
Deferred Revenue
YoY Change
Short-Term Debt	$1.252M	$1.055M
YoY Change	18.59%	69.75%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.417M	$2.173M
YoY Change	11.22%	222.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$62.98K	$141.1K
YoY Change	-55.36%
Total Long-Term Liabilities	$62.98K	$141.1K
YoY Change	-55.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.417M	$2.173M
Total Long-Term Liabilities	$62.98K	$141.1K
Total Liabilities	$2.480M	$2.314M
YoY Change	7.16%	243.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.799M	-$6.823M
YoY Change	28.95%	93.61%
Common Stock	$50.78K	$40.41K
YoY Change	25.66%	6.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.262M	-$1.464M
YoY Change
Total Liabilities & Shareholders Equity	$217.6K	$849.8K
YoY Change	-74.39%	8118.86%

Cashflow Statement

Concept	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$269.1K	-$747.9K
YoY Change	-64.01%	-45.53%
Depreciation, Depletion And Amortization	$1.342K	$190.00
YoY Change	606.32%	0.0%
Cash From Operating Activities	-$155.6K	-$136.5K
YoY Change	14.01%	-66.27%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	155.9K	140.5K
YoY Change	10.99%	-64.67%
NET CHANGE
Cash From Operating Activities	-155.6K	-136.5K
Cash From Investing Activities		0.000
Cash From Financing Activities	155.9K	140.5K
Net Change In Cash	310.0	4.000K
YoY Change	-92.25%	-156.9%
FREE CASH FLOW
Cash From Operating Activities	-$155.6K	-$136.5K
Capital Expenditures		$0.00
Free Cash Flow		-$136.5K
YoY Change		-66.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	us-gaap	Notes Payable Current Related Party Type Extensible Enumeration NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2	us-gaap	Notes Payable Current Related Party Type Extensible Enumeration NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001852707
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-05-31
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity File Number EntityFileNumber	000-56262
CY2024Q2	dei	Entity Registrant Name EntityRegistrantName	BETTER FOR YOU WELLNESS, INC.
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2903933
CY2024Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	1349 East Broad Street
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbus
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43205
CY2024Q2	dei	City Area Code CityAreaCode	888
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	287-7555
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q2	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	507804946
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2026
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1716
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8565
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2634
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17379
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4634
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5152
CY2024Q2	us-gaap	Inventory Net InventoryNet	54988
CY2024Q1	us-gaap	Inventory Net InventoryNet	55416
CY2024Q2	us-gaap	Assets Current AssetsCurrent	82958
CY2024Q1	us-gaap	Assets Current AssetsCurrent	69552
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3918
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5260
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	130742
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	146454
CY2024Q2	us-gaap	Assets Assets	217618
CY2024Q1	us-gaap	Assets Assets	221266
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	724107
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	601487
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	173819
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	85823
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	474068
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	449287
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	199611
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	165843
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67758
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65765
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	777619
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	766419
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2416982
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2134624
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	62984
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	80689
CY2024Q2	us-gaap	Liabilities Liabilities	2479966
CY2024Q1	us-gaap	Liabilities Liabilities	2215313
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	998796
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	998796
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	70
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	507804946
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419509183
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	50783
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	41953
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6485445
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6493465
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8798676
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8529535
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-2262348
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1994047
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	217618
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	221266
CY2024Q2	bfyw	Merchandise Sales Amount MerchandiseSalesAmount	5689
CY2023Q2	bfyw	Merchandise Sales Amount MerchandiseSalesAmount	1850
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5319
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	932
CY2024Q2	us-gaap	Gross Profit GrossProfit	370
CY2023Q2	us-gaap	Gross Profit GrossProfit	918
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	560
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	392950
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	225414
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	312056
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	225974
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	705006
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-225603
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-704088
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	43538
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	43797
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43538
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43797
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-269141
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-747885
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	486026424
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	486026424
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	404081291
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	404081291
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1101847
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	950
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	384438
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-747885
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1464344
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1994047
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	840
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-269141
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-2262348
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-269141
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-747885
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	840
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	385388
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1430
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	25196
CY2024Q2	bfyw	Amortization Of Debt Premium AmortizationOfDebtPremium	9770
CY2023Q2	bfyw	Amortization Of Debt Premium AmortizationOfDebtPremium	0
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1342
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	194
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5931
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	553
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-428
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-563
CY2024Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	12745
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-7562
CY2024Q2	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-5152
CY2023Q2	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19857
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8538
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94380
CY2024Q2	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-33768
CY2023Q2	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-18600
CY2024Q2	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	87996
CY2023Q2	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	100160
CY2024Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0
CY2023Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-245
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-155629
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-136497
CY2024Q2	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	155939
CY2023Q2	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	140500
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	155939
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	140500
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	310
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4003
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1716
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13773
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2026
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17776
CY2024Q2	bfyw	Preferred Stock Issued For Asset Purchase In The Future Value PreferredStockIssuedForAssetPurchaseInTheFutureValue	298796
CY2023Q2	bfyw	Preferred Stock Issued For Asset Purchase In The Future Value PreferredStockIssuedForAssetPurchaseInTheFutureValue	0
CY2024Q2	bfyw	Preferred Stock Issuable For Asset Purchase In The Future Value PreferredStockIssuableForAssetPurchaseInTheFutureValue	1204
CY2024Q2	bfyw	Common Share Issuable For Conversion Of Deferred Compensation CommonShareIssuableForConversionOfDeferredCompensation	8800
CY2024Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">Reclassification of Prior Year Presentation</div></div></div></div></div><div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"><div style="font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"> </div></div></div></div><div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to Consolidated Statements of Cash Flows for three months period ended May 31, 2024, to reclassification of accounts payable to note payable related party of $131,158. This change in reclassification does not affect previously reported cash flows from operating activities in Consolidated Statements of Cash Flows.</div></div></div></div>
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">On an ongoing basis, the Company evaluates its estimates, including those related to the bad debt allowance, sales returns, stock-based compensation, beneficial conversion features, useful lives of property and equipment, income taxes, and contingent liabilities, among others. The Company bases its estimates on assumptions, both historical and forward looking, that are believed to be reasonable, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities.</div></div>
CY2024Q2	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	2026
CY2024Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	1716
CY2024Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risks</div></div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Financial instruments that potentially subject the Company to significant concentration of credit risk primarily consist of cash, cash equivalents, and accounts receivable. As of May 31, 2024 and February 28, 2024, the Company’s cash was held by financial institutions that management believes have acceptable credit. Accounts receivables are typically unsecured. The risk with respect to accounts receivable is mitigated by regular credit evaluations that the Company performs on its distribution partners and its ongoing monitoring of outstanding balances.</div></div>
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8565
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2634
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2024Q2	us-gaap	Inventory Net InventoryNet	54988
CY2024Q1	us-gaap	Inventory Net InventoryNet	55416
CY2024Q1	bfyw	Inventory Obsolescence InventoryObsolescence	0
CY2024Q2	bfyw	Inventory Obsolescence InventoryObsolescence	0
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2024	bfyw	Valuation Allowance On Deferred Tax Assets ValuationAllowanceOnDeferredTaxAssets	1
CY2024Q2	bfyw	Valuation Allowance On Deferred Tax Assets ValuationAllowanceOnDeferredTaxAssets	1
CY2024Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	21024
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	480
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2024Q2	bfyw	Disclosure In Entirety Of Convertible Note DisclosureInEntiretyOfConvertibleNote	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Note 4 - Convertible Notes Payable</div></div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> <div> <table style="text-align:start; border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;margin-right : auto;"> <tr> <td style="border-style: none; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; padding: 0px; vertical-align: top; width: 8pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> </td> <td style="border-style: none; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; padding: 0px; vertical-align: top; width: 18pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">(A)</div></div> </td> <td style="border-style: none; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; padding: 0px; vertical-align: top; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the "Note"). The Note bears an original issue discount of $31,000, and interest of 12% per year and had an original maturity date of April 12, 2023 (the "Maturity Date").</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">On June 7, 2022, the Company entered into a second Securities Purchase Agreement with Mast Hill Fund, L.P., Pursuant to the June 7, 2022 Security Purchase Agreement, Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The Note bears an original issue discount of $31,000, each bear interest of 12% per year and had an original maturity date of June 7, 2023 (the “Maturity Date”).</div></div> </td> </tr> </table> </div> <div> <table style="text-align:start; border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;margin-right : auto;"> <tr> <td style="padding: 0px; vertical-align: top; width: 8pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> </td> <td style="padding: 0px; vertical-align: top; width: 18pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> </td> <td style="padding: 0px; vertical-align: top; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">On September 18, 2023, the Company entered into an amendment of both promissory. The outstanding principal balance of the notes increased by $40,891 and $40,023, respectively. The interest rate on both notes has been increased to 18% as a result of the amendment, and the maturity date has been extended to September 13, 2024. Because the fair value of consideration issued was greater than 10% of the present value of the remaining cash flows under the modified notes, the transaction was treated as a debt extinguishment and reissuance of new debt instruments pursuant to the guidance of ASC 470-50. A loss on debt extinguishment was recorded of $80,914 on the consolidated statement of operations in 10K filled on September 10, 2024. There was no change in fair value of the debt instruments subsequent to the amendment date, since the extinguishment transaction occurred on September 18, 2023.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The above notes are convertible into shares of the Company's common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing. Further, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Mast Hill, pursuant to which the Company is obligated to file a registration statement. On October 11, 2022, Mast Hill Fund agreed to extend the timeframes in section 2(a) of the Registration Rights Agreement dated April 12, 2022 until February 9, 2023, and to have the Registration Statement become effective on or before February 9, 2037.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense on both the Mast Hill Fund promissory notes were $31,802, and $18,600 for the three months period ended May 31, 2024 and 2023 respectively.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense payable on both the Mast Hill Fund promissory notes were $196,726 and $164,924 as of May 31, 2024 and February 28, 2024 respectively.</div></div> </td> </tr> </table> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div> <table style="text-align:start; border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;margin-right : auto;"> <tr> <td style="padding: 0px; vertical-align: top; width: 8pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> </td> <td style="padding: 0px; vertical-align: top; width: 18pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">(B)</div></div> </td> <td style="padding: 0px; vertical-align: top; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; text-indent: -0.02in; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">On January 17, 2024, the Company entered into a convertible promissory note with 1800 Diagonal Lending, LLC with the principal amount of $65,000 of which $60,000 was received in cash and $5,000 was recorded as transaction fees. The note bears the interest rate of 12% per annum and matures at November 30, 2024. The note includes a conversion discount of 35 % and the conversion price shall be determined on the basis of the average of three lowest trading price of Common stock during the ten trading days period and is limited to convert no more than 4.99% of the issued and outstanding Common Stock at time of conversion at any one time. On July 19, 2024, the Default Notice demanded the immediate payment of $189,162, together with principal outstanding, accrued interest and “Default Interest,” as provided for in the Note. This note is currently in default.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.02in; text-align: justify; text-indent: -0.02in; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense on the 1800 Diagonal Lending promissory note was $1,966, and $0 for the three months period ended May 31, 2024 and 2023 respectively.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The Company accounted for the Diagonal Note under ASC 480 and recorded an aggregate debt premium of $35,000 with a charge to interest expense</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"> over the tenure of the note.</div></div><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> The total debt premium amortized on the note was $9,770 and $0 for the three months period ended May 31, 2024 and 2023 respectively.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense payable on 1800 Diagonal Lending promissory note was $2,885 and $919 as of May 31, 2024 and February 28, 2024 respectively.</div><div style="white-space:pre-line; color: rgb(0, 0, 0); font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="white-space:pre-line; color: rgb(0, 0, 0); font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> </td> </tr> </table> </div>
CY2024Q2	bfyw	Gain Loss On Extinguishment Of Debt GainLossOnExtinguishmentOfDebt	80914
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5260
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2323
CY2024Q2	bfyw	Equipment Acquired Net Of Depreciation EquipmentAcquiredNetOfDepreciation	0
CY2024Q1	bfyw	Equipment Acquired Net Of Depreciation EquipmentAcquiredNetOfDepreciation	4869
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1342
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1932
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3918
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5260
CY2024Q2	us-gaap	Depreciation Depreciation	1342
CY2023Q2	us-gaap	Depreciation Depreciation	194
CY2024Q2	bfyw	Rental Payments RentalPayments	6650
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	200215
CY2023Q2	bfyw	Treasury Rate TreasuryRate	0.12
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	79800
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	66500
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	146300
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15558
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	130742
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67758
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	62984
CY2024Q2	bfyw	Schedule Of Additional Information Pertaining To Our Leases ScheduleOfAdditionalInformationPertainingToOurLeases	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The following table set forth additional information pertaining to our leases:</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div> <table style="text-align:start; border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;margin-right : auto;margin-right : auto;"> <tr> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-family: "Times New Roman", Times, serif; font-size: 10pt;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: left;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">For the three months ending May 31,</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1pt solid windowtext; white-space: nowrap; width: 11%;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"><div style="white-space: nowrap;font-weight:bold;display:inline;">2024</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1pt solid windowtext; white-space: nowrap; width: 11%;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"><div style="white-space: nowrap;font-weight:bold;display:inline;">2023</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:white;"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); padding: 0px; vertical-align: bottom; width: 74%; font-family: "Times New Roman", Times, serif; font-size: 10pt;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Weighted average remaining lease term – operating leases</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: left;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0in; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">1.8 years</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: left;background-color:rgb(204, 238, 255);"> <div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal;"> </div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: left;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: left; line-height: 12pt; white-space: nowrap; margin-left: 0in; text-indent: 0in;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:rgb(204, 238, 255);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0in; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">2.8 years</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: left;background-color:rgb(204, 238, 255);"> <div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal;"> </div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); padding: 0px; vertical-align: bottom; width: 74%; font-family: "Times New Roman", Times, serif; font-size: 10pt;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Weighted average discount rate – operating leases</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: left;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: right;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0in; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">3.81</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: left;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">%</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: left;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: left; line-height: 12pt; white-space: nowrap; margin-left: 0in; text-indent: 0in;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: right;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0in; line-height: 12pt; white-space: nowrap;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">3.81</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; text-align: left;background-color:rgba(255, 255, 255, 0);"> <div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">%</div></div> </td> </tr> </table>
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0381
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0381
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	173819
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	85823
CY2024Q2	bfyw	Stock Purchase Warrant Liability Description StockPurchaseWarrantLiabilityDescription	On April 18, 2022, we entered into a Standby Equity Commitment Agreement with MacRab LLC, a Florida limited liability company providing us with an option to sell up to $5,000,000 worth of our Common Stock, par value $0.0001, to MacRab LLC, in increments, over the period ending 24 months after the date that the Company’s registration statement is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. Additionally, we issued MacRab LLC a Common Stock purchase warrant for the purchase of 1,785,714 shares of our common stock as a commitment fee in connection with the execution of the Standby Equity Commitment Agreement. We also entered into a Registration Rights Agreement with the Investor requiring the Company to file a registration statement providing for the registration of the Common Stock issuable to MacRab LLC under the Standby Equity Commitment Agreement and their common stock purchase warrant, and the subsequent resale by MacRab LLC of such Common Stock.
CY2022Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	22320
CY2024Q2	bfyw	Non Cancelable Warrants Percentage NonCancelableWarrantsPercentage	0.08
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1.20
CY2024Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	998796
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	998796
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	507804946
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	507804946
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419509183
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419509183
CY2024Q2	bfyw	Purchase Commitment Shares PurchaseCommitmentShares	4960000
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	300000
CY2024Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	300000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	20000000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber	14000000
CY2024Q2	bfyw	Stock Option Description StockOptionDescription	6,000,000 shares vest over the next year
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	25
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4853749
CY2024Q2	us-gaap	Share Price SharePrice	22
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.72
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0101
CY2022Q1	us-gaap	Share Price SharePrice	11
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.63
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0126
CY2024Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0
CY2023Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	384438
CY2024Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	1204
CY2023Q4	bfyw	Asset Acquisition Equipment AssetAcquisitionEquipment	4869
CY2023Q4	bfyw	Asset Acquistion Equipment Inventory AssetAcquistionEquipmentInventory	51374
CY2023Q4	bfyw	Asset Acquisition Aggregate Assets Acquired AssetAcquisitionAggregateAssetsAcquired	56243
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001575872-24-001005-index-headers.html	Edgar Link	pending
0001575872-24-001005-index.html	Edgar Link	pending
0001575872-24-001005.txt	Edgar Link	pending
0001575872-24-001005-xbrl.zip	Edgar Link	pending
bf065_ex31-1.htm	Edgar Link	pending
bf065_ex31-2.htm	Edgar Link	pending
bf065_ex32-1.htm	Edgar Link	pending
bfyw-20240531.htm	Edgar Link	pending
bfyw-20240531.xsd	Edgar Link	pending
bfyw-20240531_cal.xml	Edgar Link	unprocessable
bfyw-20240531_def.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
bfyw-20240531_lab.xml	Edgar Link	unprocessable
bfyw-20240531_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bfyw-20240531_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BFYW
Better For You Wellness, Inc. Stock $bfyw

2024 Q2 Form 10-Q Financial Statement

#000157587224001005 Filed on September 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFYW Better For You Wellness, Inc. Stock $bfyw

2024 Q2 Form 10-Q Financial Statement

#000157587224001005 Filed on September 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFYW
Better For You Wellness, Inc. Stock $bfyw